📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Celmatix

1.1 - Company Overview

Celmatix Logo

Celmatix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of preclinical discovery and development focused on women’s ovarian health, including target identification and validation for endometriosis, PCOS, and ovarian senescence; collaborative discovery, development, and commercialization with Evotec and Bayer; contraceptive target discovery supported by the Bill & Melinda Gates Foundation; and proprietary cohorts, annotations, and NLP-driven research tools.

Products and services

  • Collaborative Discovery, Development, & Commercialization: Industry-partnered initiative with Evotec and Bayer that delivers novel PCOS targets and co-develops new women’s health treatments, advancing target discovery into development
  • Preclinical Discovery & Development: Preclinical-grade research collaboration with Evotec that identifies and validates targets for endometriosis, PCOS, and ovarian senescence to advance ovarian health
  • Contraceptive Discovery & Development: Target-centric initiative supported by the Bill & Melinda Gates Foundation that identifies novel targets for next-generation female contraceptive drug discovery

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Celmatix

Medicinal Genomics Logo

Medicinal Genomics

HQ: The Netherlands Website
  • Description: Provider of genomics-driven testing and breeding solutions for medical cannabis and hemp, including the PathoSEEK qPCR-based microbial safety testing platform and detection assays for flower, extracts, and infused products; SenSATIVAx DNA purification kits; FemINDICAtor qPCR plant sex testing; and genomic services to identify markers for desirable traits and accelerate breeding programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medicinal Genomics company profile →
Nightingale Health Logo

Nightingale Health

HQ: Finland Website
  • Description: Provider of pioneering blood-testing services and proprietary blood analysis technology that delivers deep health insights, identifies disease risks from a single sample, and measures the effects of lifestyle interventions. Offers Nightingale Pro data platform for detecting population-level disease risks and preventative health needs, and biomarker analysis services for researchers across blood, urine, and dried blood spot samples.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nightingale Health company profile →
RNAissance Ag Logo

RNAissance Ag

HQ: United States Website
  • Description: Provider of ribonucleic acid and RNAi products, offering innovative technology for large-scale fermentation-based production of exogenous RNAi, addressing mass production challenges and enabling farmers to protect and improve crops and cattle.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RNAissance Ag company profile →
Caribou Biosciences Logo

Caribou Biosciences

HQ: United States Website
  • Description: Provider of CRISPR genome-editing technologies and allogeneic CAR-T cell therapies for oncology. Offers chRDNA to enhance precision and reduce off-target effects; off-the-shelf CAR-T therapies for hematologic malignancies and autoimmune diseases; and candidates CB-010 (anti-CD19 for B cell non-Hodgkin lymphoma), CB-011 (anti-BCMA for multiple myeloma), and CB-012 (anti-CLL-1 for acute myeloid leukemia).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caribou Biosciences company profile →
Lynx Therapeutics Logo

Lynx Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology diagnostic and therapeutic solutions, including Lynxgen Therapeutics LongSAGE mRNA for mRNA sequence analysis to support precision treatment and diagnostics; globally distributed ELISA kits for detecting biomarkers such as chemokines and COVID-19; and exosome-based methods for diagnostics and therapy addressing antibiotic resistance in Mycoplasma pneumoniae.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lynx Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Celmatix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Celmatix

2.2 - Growth funds investing in similar companies to Celmatix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Celmatix

4.2 - Public trading comparable groups for Celmatix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Celmatix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Celmatix

What does Celmatix do?

Celmatix is a provider of preclinical discovery and development focused on women’s ovarian health, including target identification and validation for endometriosis, PCOS, and ovarian senescence; collaborative discovery, development, and commercialization with Evotec and Bayer; contraceptive target discovery supported by the Bill & Melinda Gates Foundation; and proprietary cohorts, annotations, and NLP-driven research tools.

Who are Celmatix's competitors?

Celmatix's competitors and similar companies include Medicinal Genomics, Nightingale Health, RNAissance Ag, Caribou Biosciences, and Lynx Therapeutics.

Where is Celmatix headquartered?

Celmatix is headquartered in United States.

How many employees does Celmatix have?

Celmatix has 1,000 employees 🔒.

When was Celmatix founded?

Celmatix was founded in 2010 🔒.

What sector and industry vertical is Celmatix in?

Celmatix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Celmatix

Who are the top strategic acquirers in Celmatix's sector and industry

Top strategic M&A buyers and acquirers in Celmatix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Celmatix?

Top strategic M&A buyers groups and sectors for Celmatix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Celmatix's sector and industry vertical

Which are the top PE firms investing in Celmatix's sector and industry vertical?

Top PE firms investing in Celmatix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Celmatix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Celmatix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Celmatix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Celmatix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Celmatix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Celmatix?

The key public trading comparables and valuation benchmarks for Celmatix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Celmatix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Celmatix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Celmatix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Celmatix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Celmatix's' sector and industry vertical?

Access recent funding rounds and capital raises in Celmatix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Celmatix